[1] |
王龙平,曾斌,白文芳,等.食管癌围术期的物理治疗进展[J].中国康复理论与实践,2019,10(25):1168-1171.
|
[2] |
中华人民共和国国家卫生健康委员会.食管癌诊疗规范(2018年版)[J].中华消化病与影像杂志(电子版),2019,9(4):158-192.
|
[3] |
乔宇峰,于振涛.食管鳞癌新辅助治疗现状与争议[J].中国肿瘤临床,2019,46(9):473-478.
|
[4] |
沈琳,刘云鹏,潘宏铭,等.消化道恶性肿瘤合理用药指南[J].中国合理用药探索,2017,14(9):5-54.
|
[5] |
Kelsen DP,Winter KA,Gunderson LL,et al.Long-term results of RTOG trial 8911 (USA Intergroup 113):a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer[J].J Clin Oncol,2007,25(24):3719-3725.
|
[8] |
杨冉,韩金利,张卫民,等.新辅助化疗在进展期食管癌中的疗效分析[J].中国肿瘤临床,2014,41(2):119-122.
|
[9] |
强勇,杨楠,董国华,等.紫杉醇联合顺铂新辅助化疗对Ⅲ期食管癌手术风险及预后的影响[J].临床肿瘤学杂志,2016,21(2):166-169.
|
[11] |
蔡延庆.紫杉醇联合顺铂新辅助化疗对Ⅲ期食管癌患者实施手术的风险及对预后的影响[J].中国实用医药,2019,14(3):68-69.
|
[6] |
Allum WH,Stenning SP,Bancewicz J,et al.Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer[J].J Clin Oncol,2009,27(30):5062-5067.
|
[7] |
Ando N,Kato H,Igaki H,et al.A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907)[J].Ann Surg Oncol,2012,19(1):68-74.
|
[10] |
Zheng Y,Li Y,Liu X,et al.Neoadjuvant chemotherapy followed by minimally invasive esophagectomy versus primary surgery for management of esophageal carcinoma:a retrospective study[J].J Cancer,2019,10(5):1097-1102.
|
[12] |
郑博文.不同铂类药物和紫杉醇联合在食管癌新辅助化疗中的效果分析[J].河南医学研究,2019,28(10):1826-1828.
|
[13] |
徐晓暇.多西他赛联合铂类药物治疗食管癌患者的疗效[J].中国药物经济学,2019,14(12):89-91.
|
[14] |
王晓芬,吴珊珊,蔡艾芳,等.TP 方案新辅助化疗治疗局部晚期食管癌的疗效观察[J].中国当代医药,2017,24(17):57-59.
|
[15] |
赵精洁,蒙美好,曾凯瑾.心理护理干预对胃癌术后化疗患者人格特征及生活质量的影响[J].中国肿瘤临床与康复,2015,22(1):81-84.
|
[16] |
刘海强,董建新.肿瘤内科住院患者营养风险及支持状况[J].中国卫生标准管理,2019,10(19):11-14.
|
[17] |
Dou L,Wang X,Cao Y,et al.Relationship between Postoperative Recovery and Nutrition Risk Screened by NRS 2002 and Nutrition Support Status in Patients with Gastrointestinal Cancer[J].Nutr Cancer,2020,72(1):33-40.
|
[18] |
李磊,费建东,宋利琴,等.进展期胃癌患者新辅助化疗联合腹腔镜治疗疗效及不良反应[J].中国老年学杂志,2020,2(40):516-518.
|
[19] |
谢竹音,郑志超.协同护理对进展期胃癌新辅助化疗患者营养水平的影响[J].护士进修杂志,2019,34(9):786-790.
|
[20] |
刘兰珍.新辅助化疗食管癌患者心理弹性、应对方式与生活质量的相关性研究[D].开封:河南大学,2019:1-73.
|
[21] |
青友芬.心理护理干预对宫颈癌新辅助化疗患者负性情绪及生活质量的影响[J].中国肿瘤临床与康复,2017,24(2):235-238.
|
[22] |
李东艳.支持性心理干预对直肠癌新辅助化疗患者焦虑、抑郁及生活质量的影响[D].郑州:郑州大学,2016:1-60.
|
[23] |
赵宏波.新辅助化疗联合手术治疗食管癌术后并发症分析[J].中国肿瘤外科杂志,2015,7(6):379-380.
|
[24] |
Yu Z,Li S,Liu D,et al.Society for Translational Medicine Expert Consensus on the prevention and treatment of postoperative pulmonary infection in esophageal cancer patients[J].J Thorac Dis,2018,10(2):1050-1057.
|
[25] |
康璐,袁娟,洪宇彤.微氧渗透辅助负压封闭治疗在食管癌三切口术后颈部吻合口瘘患者中的应用研究[J].护士进修杂志,2020,35(11):1043-1045.
|
[26] |
温小鹏,张广健.云南白药局部应用治疗食管癌术后食管胃颈部吻合口瘘临床观察[J].新中医,2013,45(4):100-101.
|